Peptidream Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Peptidream Inc with three other
companies in this sector in Japan:
GNI Group Limited
sales of 2.65 billion Japanese Yen [US$24.76 million]
of which 72%
was Medicine Business),
Medical Data Vision Co Ltd
(3.23 billion Japanese Yen [US$30.16 million]
of which 51%
was Data profit utilization service), and
Symbio Pharmaceuticals Ltd
(3.44 billion Japanese Yen [US$32.20 million]
During the year ended June of 2017, sales at
Peptidream Inc were ¥4.90 billion (US$45.78 million).
increase of 13.1%
versus 2016, when the company's sales were ¥4.33 billion.
This was the fifth consecutive year of sales increases at Peptidream Inc
(and since 2012, sales have increased a total of 1,720%).